Oculoplastics
A new method of full thickness skin graft fixation, 1979 ⏩
n=109, 6m-4.5y
A technique of free full thickness skin graft fixation utilizing central and paracentral
sutures between the graft and the depths of the recipient bed thus eliminating the need for a firm pressure bandage and hospital admission,
Teprotumumab for the Treatment of Active Thyroid Eye Disease (OPTIC), 2020 ⏩
n=83, 24w
Study Question: Teprotumumab q3w VS placebo for active thyroid eye disease
Study results: Regression to Clinical Activity Score of 0 or 1 was seen in 59% in the tx group vs. 21% . Mean change in proptosis was −2.82 mm vs. −0.54 mm in the placebo group. Diplopia response was 68% vs. 29% and the mean change in GO-QOL overall score was 13.79 points in the treatment group vs. 4.43 points in the placebo group. $ Horizon Therapeutics
Abbreviations used on this page:
m-months
n - number of patients
tx - treatment
w - weeks
y-years
n=109, 6m-4.5y
A technique of free full thickness skin graft fixation utilizing central and paracentral
sutures between the graft and the depths of the recipient bed thus eliminating the need for a firm pressure bandage and hospital admission,
Teprotumumab for the Treatment of Active Thyroid Eye Disease (OPTIC), 2020 ⏩
n=83, 24w
Study Question: Teprotumumab q3w VS placebo for active thyroid eye disease
Study results: Regression to Clinical Activity Score of 0 or 1 was seen in 59% in the tx group vs. 21% . Mean change in proptosis was −2.82 mm vs. −0.54 mm in the placebo group. Diplopia response was 68% vs. 29% and the mean change in GO-QOL overall score was 13.79 points in the treatment group vs. 4.43 points in the placebo group. $ Horizon Therapeutics
Abbreviations used on this page:
m-months
n - number of patients
tx - treatment
w - weeks
y-years
$ - study funding, when relevant
--------------------
🚧 This is just the beginning, we are still improving this page. If you have any remarks or suggestions, please don't hesitate to contact us using the form at the bottom of the page.
--------------------
🚧 This is just the beginning, we are still improving this page. If you have any remarks or suggestions, please don't hesitate to contact us using the form at the bottom of the page.
Comments
Post a Comment